laitimes

Today's subscription: Tianyuan Environmental Protection, Pingao Shares, Chunli Medical

Wuhan Tianyuan Environmental Protection Co., Ltd

Sponsor (lead underwriter): Zhongtian Guofu Securities Limited

Release Status:

Today's subscription: Tianyuan Environmental Protection, Pingao Shares, Chunli Medical

Company Profile:

Tianyuan Environmental Protection is a professional environmental comprehensive treatment service provider engaged in landfill leachate and high-difficulty sewage treatment, mainly to provide customers with process design, equipment processing, equipment integration, engineering construction, operation services and other integrated solutions for landfill leachate and high-difficulty sewage treatment, the main business includes environmental protection equipment research and development and manufacturing and integration, environmental protection engineering construction and environmental protection project operation services.

As of the date of signing of the prospectus, Tianyuan Group held 141.565 million shares of Tianyuan Environmental Protection Shares, accounting for 46.04% of the total share capital of the Company before the issuance, and was the controlling shareholder of Tianyuan Environmental Protection. The actual controllers are Huang Kaiming, Huang Zhaowei and Li Juan.

After deducting the issuance fee, the funds raised by Tianyuan Environmental Protection will be used for the construction project of Tianbai Sewage Treatment Plant (Phase III) in Cuiping District, Yibin City, the upgrading project of intelligent manufacturing production line of environmental protection equipment, the upgrading and transformation construction project of R&D center, the construction project of marketing center and marketing network, and the supplementary working capital.

Guangzhou Pingao Software Co., Ltd

Sponsor (lead underwriter): Minsheng Securities Co., Ltd

Today's subscription: Tianyuan Environmental Protection, Pingao Shares, Chunli Medical

Pingao Co., Ltd. is a professional cloud computing and industry information service provider in China, providing full-stack enterprise-level cloud platforms and information services from IaaS infrastructure layer, PaaS platform layer, DaaS data layer to SaaS software layer for customers in rail transportation, government, telecommunications, public security, automotive, finance, education, military and other industries.

Beijing Shanggao directly holds 47,224,294 shares of the company, accounting for 55.6946% of the total share capital before the issuance, and is the controlling shareholder of the company. The actual controllers of the company are Huang Hai, Zhou Jing and Liu Xin. Huang Hai, Zhou Jing and Liu Xin hold 31.00%, 30.00% and 30.00% of the shares of Beijing Shanggao respectively.

After deducting the issuance fee, the funds raised by Pingao will be used for the information technology innovation cloud platform, the exclusive information cloud service platform, the construction of the Pingao Building, and the supplementary working capital.

Beijing Chunli Zhengda Medical Device Co., Ltd

Sponsor (lead underwriter): Huatai United Securities Co., Ltd

Today's subscription: Tianyuan Environmental Protection, Pingao Shares, Chunli Medical

Chunli Medical is a leading manufacturer of orthopedic medical devices in China, and its main business is the research and development, production and sales of implantable orthopedic medical devices. The company's main products are joint prosthesis products and spinal implant products, of which joint prosthesis products cover hip, knee, shoulder and elbow four major human joints, spine implant products are a full range of product portfolio of spinal internal fixation system.

The actual controllers of Chunli Medical are Shi Chunbao and Yue Shujun. Prior to the offering, Shi Chunbao directly held 114 million domestic shares of the company (accounting for 32.87% of the total number of shares), and Yue Shujun directly held 95.4479 million domestic shares of the company (accounting for 27.60% of the total number of shares). Mr. and Mrs. Shi Chunbao and Yue Shujun directly hold a total of 209 million shares of the company (accounting for 60.47% of the total number of shares) and are the co-controlling shareholders of the company.

After deducting the issuance costs, the funds raised by Chunli Medical will be used for the comprehensive construction project of orthopedic implants and supporting materials, the construction project of R&D center, the construction project of marketing network, and the project of supplementary working capital.